These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 38306045)
21. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline. Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358 [TBL] [Abstract][Full Text] [Related]
22. The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease. Jung Y; Damoiseaux JS Brain; 2024 Jan; 147(1):12-25. PubMed ID: 37540027 [TBL] [Abstract][Full Text] [Related]
23. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028 [TBL] [Abstract][Full Text] [Related]
24. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027 [TBL] [Abstract][Full Text] [Related]
25. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients. Huang Y; Li Y; Xie F; Guo Q CNS Neurosci Ther; 2022 Dec; 28(12):2195-2205. PubMed ID: 36074638 [TBL] [Abstract][Full Text] [Related]
26. Serum neurofilament light chain level as a predictor of cognitive stage transition. Lee EH; Kwon HS; Koh SH; Choi SH; Jin JH; Jeong JH; Jang JW; Park KW; Kim EJ; Kim HJ; Hong JY; Yoon SJ; Yoon B; Kang JH; Lee JM; Park HH; Ha J Alzheimers Res Ther; 2022 Jan; 14(1):6. PubMed ID: 34996525 [TBL] [Abstract][Full Text] [Related]
27. Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain. Chen CY; Chiu CC; Huang CY; Cheng YC; Huang MC; Kuo PH; Chen WY BMC Geriatr; 2024 Apr; 24(1):344. PubMed ID: 38627748 [TBL] [Abstract][Full Text] [Related]
28. A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease. Sugarman MA; Zetterberg H; Blennow K; Tripodis Y; McKee AC; Stein TD; Martin B; Palmisano JN; Steinberg EG; Simkin I; Budson AE; Killiany R; O'Connor MK; Au R; Qiu WWQ; Goldstein LE; Kowall NW; Mez J; Stern RA; Alosco ML Neurobiol Aging; 2020 Oct; 94():60-70. PubMed ID: 32585491 [TBL] [Abstract][Full Text] [Related]
29. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723 [TBL] [Abstract][Full Text] [Related]
30. The Potential of Neurofilament Light as a Biomarker in Alzheimer's Disease. Xiong YL; Meng T; Luo J; Zhang H Eur Neurol; 2021; 84(1):6-15. PubMed ID: 33477142 [TBL] [Abstract][Full Text] [Related]
31. Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies. Bolsewig K; van Unnik AAJM; Blujdea ER; Gonzalez MC; Ashton NJ; Aarsland D; Zetterberg H; Padovani A; Bonanni L; Mollenhauer B; Schade S; Vandenberghe R; Poesen K; Kramberger MG; Paquet C; Bousiges O; Cretin B; Willemse EAJ; Teunissen CE; Lemstra AW; Neurology; 2024 Jun; 102(12):e209418. PubMed ID: 38830138 [TBL] [Abstract][Full Text] [Related]
40. The prognostic utility of CSF neurogranin in predicting future cognitive decline in the Alzheimer's disease continuum: A systematic review and meta-analysis with narrative synthesis. Yoong SQ; Lu J; Xing H; Gyanwali B; Tan YQ; Wu XV Ageing Res Rev; 2021 Dec; 72():101491. PubMed ID: 34688925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]